Brazil Cancer Drugs Market Clinical Trials Report 2024: Brazil Emerges as a Leading Force in Cancer Drug Clinical Trials
12 août 2024 04h44 HE
|
Research and Markets
Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "Brazil Cancer Drugs Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. With Brazil making significant strides...
Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC
06 août 2024 08h00 HE
|
Science 37, Inc.
Science 37 opens new, state-of-the-art facility, to enhance collaboration and improve patient recruitment and study support for clinical trials.
Innovative AI-enabled Clinical Trial Strategic Profiling Report 2024: Integration of Real-world Insights into Trial Management is Propelling AI Adoption in Clinical Trials
06 août 2024 05h40 HE
|
Research and Markets
Dublin, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The "Innovative AI-enabled Clinical Trial Companies: Strategic Profiling and Growth Opportunities" report has been added to ResearchAndMarkets.com's...
EU (European Union) Clinical Trial Regulation 536/2014 Overview and Implementation Experience Training Course - November 11-12th 2024 and On-Demand
22 juil. 2024 07h48 HE
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "EU (European Union) Clinical Trial Regulation 536/2014: Overview and Implementation Experience Training Course" conference has been added to ...
Virtual Clinical Trials Market Analysis and Forecasts, 2024-2032: Technological Innovation and Patient-Centric Models Spearhead Industry Evolution
02 juil. 2024 10h49 HE
|
Research and Markets
Dublin, July 02, 2024 (GLOBE NEWSWIRE) -- The "Virtual Clinical Trials Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials
27 juin 2024 09h41 HE
|
Science 37, Inc.
Nearly 20 studies have successfully leveraged Science 37's medical and operational expertise to boost patient recruitment and enrollment activities.
CORRECTION-- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial
12 juin 2024 15h55 HE
|
Science 37, Inc.
Science 37, a leader in enhancing patient access to clinical trials, surpasses enrollment targets and helps accelerate Phase 2 rare disease study.
Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial
12 juin 2024 08h00 HE
|
Science 37, Inc.
Science 37, a leader in enhancing patient access to clinical trials, surpasses enrollment targets and helps accelerate Phase 2 rare disease study.
Clinical Trial Monitoring 2-Day Online Training Course: July 29-30, 2024 - Understand the Importance of Compliance with the Latest GCP Standards
24 mai 2024 07h40 HE
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Clinical Trial Monitoring Training Course" conference has been added to ResearchAndMarkets.com's offering. With regulatory inspectors increasingly...
Citeline Introduces Global Patient Insights
15 mai 2024 09h00 HE
|
Citeline
Citeline announces the launch of Global Patient Insights, the industry’s most comprehensive view of the worldwide patient landscape.